Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Colorcon
Julphar
Merck
Fuji

Generated: May 22, 2019

DrugPatentWatch Database Preview

Novel Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?

NOVEL LABS INC has sixty approved drugs.

There are two tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc
US Patents:0
Tradenames:45
Ingredients:44
NDAs:60

Drugs and US Patents for Novel Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 204330-001 Mar 16, 2016 AA RX No No ➤ Sign Up ➤ Sign Up
Novel Labs Inc PHENELZINE SULFATE phenelzine sulfate TABLET;ORAL 200181-001 Dec 8, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Novel Labs Inc ZOLPIDEM TARTRATE zolpidem tartrate TABLET;SUBLINGUAL 204299-002 Jun 3, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Novel Labs Inc TEMAZEPAM temazepam CAPSULE;ORAL 071457-001 Apr 21, 1987 AB RX No No ➤ Sign Up ➤ Sign Up
Novel Labs Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 204021-004 Jun 12, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Novel Labs Inc TEMAZEPAM temazepam CAPSULE;ORAL 071457-002 Jun 22, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fuji
Daiichi Sankyo
McKesson
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.